QRL-101 reduces motor neuron excitability in healthy volunteers
An experimental oral small molecule being developed by Quralis for amyotrophic lateral sclerosis (ALS) reduced motor neuron excitability…
Articles by Margarida Maia, PhD
Cognixion seeks ALS patients for clinical trial of BCI headset
Cognixion is recruiting adults with amyotrophic lateral sclerosis (ALS) for a clinical trial testing ONE Axon-R, a wearable headset…
39 Canadians in ALS community presented with Coronation Medals
The ALS Society of Canada (ALS Canada) has named 39 Canadians to be presented the King Charles III Coronation…
Smartphone app may help in monitoring ALS beyond clinic visits
Using a smartphone app to self-assess ALS Functional Rating Scale-Revised (ALSFRS-R) scores, a standardized measure of amyotrophic lateral sclerosis…
MDA Shamrocks fundraising campaign underway across US
The Muscular Dystrophy Association (MDA) has rolled out its St. Patrick’s Day fundraising campaign, MDA Shamrocks —…
ALS patient’s story to be highlight of Atlanta Night of Hope Gala
This year’s Atlanta Night of Hope Gala will showcase how patient April Byars has been navigating life since her…
15 nonprofits join to form new ALS group, ALS United
Fifteen nonprofit organizations across the U.S. formed a new ALS group, ALS United, to better address the needs of…
Less opioid use for ALS patients on invasive ventilation, study finds
People with amyotrophic lateral sclerosis (ALS) who choose invasive ventilation to help with breathing less frequently require opioids to…
Radicava delays time to certain ALS disease progression milestones
It takes longer for people with amyotrophic lateral sclerosis (ALS) who are being treated with Radicava (edaravone) to…
New York scores highest on ALS state policy report cards
New York received the highest mark on the ALS Association’s latest report cards, which grade states based on how…